Unwrapping the Genomic Characteristics of Urothelial Bladder Cancer and Successes With Immune Checkpoint Blockade Therapy

Oncogenesis - United States
doi 10.1038/s41389-017-0013-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Concurrent Therapy With Immune Checkpoint Inhibitors and TNFα Blockade in Patients With Gastrointestinal Immune-Related Adverse Events

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Immune Checkpoint Blockade: Subjugation of the Masses

2017English

Nodular Regenerative Hyperplasia Associated With Immune Checkpoint Blockade

Hepatology
MedicineHepatology
2018English

Immune Checkpoint Blockade in Lymphoid Malignancies

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2016English

Radiation and Dual Checkpoint Blockade Activate Non-Redundant Immune Mechanisms in Cancer

Nature
Multidisciplinary
2015English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer

JAMA network open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy